CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 45

Industry reads hand-picked by our editors

Jun 07, 2024

Stat
How the BIOSECURE Act is already affecting U.S., Chinese life science firms
Financial Times
Weight-loss ETFs demand some heavy thinking
Reuters
AbbVie’s tight grip on Humira market raises concerns about biosimilars
C&EN
The future of click chemistry

Jun 06, 2024

Reuters
Staff at drugmaker under U.S. scrutiny worked with Chinese military scientists
Bloomberg
Cycle Pharma Offers to Buy Vanda Pharma in $466 Million Deal
Science
This biologist aims to solve the cell’s biggest mystery. Could it help cancer patients, too?

Jun 05, 2024

Science
Researchers plan to retract landmark Alzheimer’s paper containing doctored images
FirstWord Pharma
BMS cuts to fall heavily on Lawrenceville site
Fierce Biotech
Vir keeps pressure on Gilead with midphase hepatitis D data
NPR
Why Fat Joe advocates for hospital price transparency

Jun 04, 2024

Vanity Fair
Why Counterfeit Ozempic Is a Global-Growth Industry
Bloomberg
The HPV Cancer Vaccine Is Safe and Both Boys and Girls Need It
ApexOnco
ASCO 2024 movers – Affimed wins, Caribou loses

Jun 03, 2024

C&EN
New antibiotics are hard to come by. Red tape is making the problem worse
Bloomberg
Pharma’s $1 Trillion ‘Firepower’ Hangs Over Biotech Stocks in Limbo
Stat News
Beta-thalassemia drug from Agios hits goal in Phase 3 study
MIT Technology Review
The messy quest to replace drugs with electricity

May 31, 2024

NPR
A 3rd human case of bird flu detected, this one with respiratory symptoms
Axios
House China panel seeks intel briefing on biotech
The Economist
New fronts are opening in the war against malaria
The Wall Street Journal
You Can Thank Private Equity for That Enormous Doctor’s Bill

May 30, 2024

The New York Times
For Some Families of Color, a Painful Fight for a Cystic Fibrosis Diagnosis
The Financial Times
US close to deal to bankroll Moderna bird flu vaccine trial
Science
Treatments emerge for rare ‘catastrophic’ bone growth disease

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Webinar - on demand
Overcoming Data Overload — How AI and Modernization are Transforming Biopharma Custom content for Endava
Playbook
Navigating New Opportunities in China's Pharmaceutical Boom Custom content for Evaluate
Trendline
Inside the world of cell therapies Supported by 10x Genomics

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

4 major trends shaping today’s oncology market Webinar - on demand • Provided by Advisory Board
Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce
Built for the Storm: Why Prepared Systems Win in Pharma Webinar - on demand • Provided by Phase2

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.